Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell Based Assays

Sung Wook Jang's Biography



Sung Wook Jang, Investigator, National Institutes of Health (NIH)

Dr. Jang is currently a postdoctoral fellow with Dr. James Inglese at the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). He has continuously utilized tools of chemical biology to explore therapeutic avenues for a broad spectrum of disorders. His current research interest revolves around the strategic use of technology in assay development as part of the translational science focused on rare genetic diseases. These disorders are often neglected due to mechanistic complexity and a limited market hindering pharmaceutical company investments. Over the past years, he has been involved in a drug development program for inherited peripheral neuropathy called Charcot-Marie-Tooth (CMT) diseases at NIH in close partnership with a patient advocate community. His recent work represents an assay development and drug repurposing strategy for CMT as well as approaches to address fundamental issues in the use of sensitive reporters frequently plagued by their artifactual outcomes.

Sung Wook Jang Image

Identification of Molecules Targeting Inherited Genetic Diseases: a Case Study for the Gene-Dosage Disorder CMT1A

Wednesday, 23 January 2013 at 14:45

Add to Calendar ▼2013-01-23 14:45:002013-01-23 15:45:00Europe/LondonIdentification of Molecules Targeting Inherited Genetic Diseases: a Case Study for the Gene-Dosage Disorder CMT1A SELECTBIOenquiries@selectbiosciences.com

Cell-based reporter assays can be particularly enabling in the discovery of pharmacologically responsive effectors of genetic lesions.  The design and validation of this assay category and strategies for their use will be the subject of this presentation. 


Add to Calendar ▼2013-01-22 00:00:002013-01-23 00:00:00Europe/LondonCell Based AssaysSELECTBIOenquiries@selectbiosciences.com